teachers had not been taken into account. The excess rate was, therefore, much reduced.
Discussion
Most of the observations suggesting person-toperson transmission of Hodgkin's disease are anecdotal and the only controlled study that offers support to the hypothesis is that by Vianna and Polan (1974) of schools in Nassau and Suffolk, New York State. No support is provided by the Oxford study (Smith et al. 1977) but evidence is required from further studies. It should be recognized that negative studies both in lymphomas and leukemias do not necessarily mean that the disease does not have an infective basis, since the process may be too subtle for detection by the particular method employed. Indeed, experience of lymphoma in the cat, a disease of proven infectivity, has shown how difficult it can be to detect epidemiological evidence of infectivity. Epidemiological studies, however, can provide at very least quantified information about the incidence of these diseases in groups with particular types of exposure to affected individuals. This is highly relevant in view of the anxiety which is inevitably produced when patients or their contacts hear of certain reports. At present, the bulk of the evidence indicates that the risk of contacts of patients with Hodgkin's disease developing the disease is very low.
The epidemiology ofnon-Hodgkin's lymphomas has received relatively little attention perhaps because they are a histologically less well-defined group. The recent finding that the incidence of reticulum cell sarcoma is greatly increased in renal transplant patients has understandably attracted much attention and a large, multicentre study, coordinated from Oxford, of this and related questions is in progress. The cause of the increased incidence of these lymphomas is unknown but a viral or other infective basis must be among the possible explanations since so many infections are facilitated in the transplant patient. 629-631 British Medwical Journal (1972) 
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Reactivity of Antisera to Oncorna Virus Proteins with Human Leukenuia Cells
There can be little doubt that leukemia is not contagious, both from the epidemiological studies (Kinlen 1977) and from the simple observation that clinicians and nurses who look after leukumia patients do not all die of the disease. However, the involvement of-viruses in the pathogenesis of animal leukemia is now considered almost certain (see Payne 1977) .
In mice, there are at least four non-linked loci which influence susceptibility/resistance to the Friend leuktmia virus complex (Lilly & Pincus 1974) . This provides a possible explanation for the lack of epidemiological evidence for an infectious agent in the pathogenesis of these diseases in an outbred population. The recent demonstration of HLA-associated resistance factors which influence survival of patients with acute myeloid leukemia suggests that genetic constitution may also be important in the pathogenesis of human leukaemia (Oliver et al. 1977) .
So far, however, it has not been possible to isolate fully formed virus from human leukemia cells regularly. Nevertheless, there is increasing evidence that there are C-type RNA oncorna virus biochemical footprints in human leukemia cells similar to those found in animal leukemia cells. Most of this information comes from studies of reverse transcriptase (Baxt et al. 1972 , Gallo et al. 1974 ). This enzyme is responsible for initiating replication of C-type RNA virus. However, there are reports of DNA provirus sequences (Wong-Staal et al. 1976 ) and C-type virus antigens (Metzgar et al. 1976 ) in human leukaemia cells. Support for the concept that humans are often exposed to these viruses without the development of leukemia comes from the demonstration of antibodies reactive with primate C-type virus proteins in normal human sera (Prochnownik & Kirsten 1976 , Snyder et al. 1976 , Kurth et al. 1977 .
In this paper we report studies on reactivity of antisera raised against purified C-type oncorna virus proteins with human leukemia cells.
Materials and Methods
Preparation of test cells: The leukamia cells and normal cells were separated from defibrinated blood using the Ficol Triosil method and stored prior to testing in liquid nitrogen in 10 % dimethylsulphoxide and 20 % autologous serum as cryoprotectant after being frozen at 1°C/min in a planer programmed freezer (R210). On the day of testing cells were rapidly thawed, then diluted slowly in RPMI 1640, and then washed once prior to adjusting to 2 x 106/ml in medium for testing. (Oliver et al. 1977) . In brief, lpl of serum was incubated under oil with 1 p1 of cell suspension for 30 minutes at room temperature, then 5 p1l of rabbit serum was added. Incubation was continued for a further 30 minutes for leukemia blast cells, and one hour for lymphocytes. The tests were read using Wild M40 inverted microscope and percentage viability was determined using phase contrast.
Antisera: The rabbit antisera to murine Moloney leukemia virus proteins were provided by Dr Nancy Hogg and the Imperial Cancer Research Fund Department of Tumour Immunology, University College, London, and the goat antisera to simian sarcoma virus (SiSAV) were provided by Dr Weiss, Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London.
Results
Cells from a total of 28 leukemia patients with active untreated disease, 8 leukxemia patients in complete remission and off all chemotherapy (C R Lymph) and 8 normals have been studied with the two antisera against Moloney proteins and two antisera against SiSAV proteins. There was a greater percentage of cytotoxicity and more frequent reactivity with antisera against SiSAV proteins than the sera against Moloney proteins, both when tested against leukaemia cells and the normal and remission lymphocytes. However, the reactivity against the normal and remission lymphocytes was considerably less than against leukxmia cells (Figs 1 & 2) . Slightly more reactivity was detectable with anti gp 70 than p 30, particularly when the two antisera against Moloney proteins are compared. Table 1 summarizes the results with these sera and three others raised against Moloney virus proteins, as well as a control normal rabbit sera and sera raised by immunizing rabbits with androstendione in Freund's adjuvant as a control for effective immunization procedure. It can be seen that acute lymphoblastic leukemia (ALL) cells give the highest frequency of reactivity, chronic lymphatic leukemia (CLL) cells the least and acute myeloid leukemia (AML) cells an intermediate reactivity. The control sera were almost invariably negative, though there were 2 weak reactions of 50% and 25 % cytotoxicity against AML cells of the normal rabbit sera, and a weak reaction with 1 out of 11 normal human sera studied.
Discussion
The rationale for this approach to studying leukemia viruses in man comes from the observation that different species of C-type oncorna virus have antigens which share determinants to a greater or lesser extent, depending on the phylogenetic proximity of their host (Schafer et al. 1976 ). It is still too early to say from these preliminary results that the reactivity we are detecting is due to the presence of viral proteins on human leukvmia cells. Although Metzgar et al. (1976) by using zenogeneic sera raised against purified oncorna virus proteins. Strong reactivity has been demonstrated with these sera against all types of leukemia cells tested and considerably less reactivity with normal and leukxmia patients, remission lymphocytes. Critical absorption and biochemical studies are required to establish that the determinant on the leukxemia cell is related to the oncorna virus protein. Vilhelm Ellerman, a Danish physician, and Olaf Bang, a Danish veterinarian, were the first to show that a leukxmia of fowl was transmissible by cellfree filtrates and caused by a virus (Ellerman & Bang 1908) . Three years later, Peyton Rous (1911) reported that a sarcoma of fowl was also caused by a filterable agent. Doubts about the neoplastic nature of a leukxmia at that time, and difficulty in showing that tumours in other animals could be caused by viruses, resulted in the viral theory of oncogenesis falling into disrepute. The chicken neoplasias were regarded as biological oddities by many workers.
Gradually interest in the viral theory was restored as examples of virally-induced tumours were discovered in mammals, but the rebirth of viral oncology dates most clearly from the discovery of the Burkitt lymphoma and the Epstein-Barr virus (Burkitt 1972) , which provided evidence for the possibility that viruses might cause tumours in man. In chickens a different situation prevailed; leukxmias and solid tumours had been recognized for many years as a cause of economically significant losses to the poultry industry and they appeared to be contagious diseases. Research during the past 50 years to discover the xtiological relationships of these conditions and ways of controlling them is now reviewed.
Two distinct lymphomatous diseases occur in the field in domestic fowl: Marek's disease, which is caused by a herpesvirus and lymphoid leukosis, which is caused by an oncornavirus. They are the most common neoplastic diseases of the chicken, and Marek's disease, before the advent of vaccination in 1971, was the commonest cause of mortality in commercial fowl. Prior to vaccination, losses of up to 80 % of a flock could occur from
Marek's disease, and in the USA condemnation of broiler carcasses due to lymphoma formation reached 1.60% of all carcasses examined at the dressing plants (Purchase 1975) . In the UK a survey in 1971-73 of 51 laying flocks revealed that 10.6 % of mortality was caused by Marek's disease and 1.4 % by lymphoid leukosis (Randall et al. 1977 ).
Marek's Disease Pathogenesis: Marek's disease is caused by a herpesvirus and presents a complex and variable pathological picture in which both neoplastic and inflammatory changes feature (see Biggs 1973 , Nazerian 1973 , Payne et al. 1976 ). Infection of young susceptible chicks with Marek's disease virus is followed after 4 to 7 days by a short period of virus replication in lymphoid cells and reticulum cells in the thymus, spleen and bursa of Fabricius. Much viral antigen and immature virions are produced, but no cell-free infectious virus. Intranuclear inclusion bodies develop, and marked cytolysis occurs. These events stimulate an inflammatory response in these organs, the virus replication ceases, and by 14 days after infection the lesions have, to a considerable extent, resolved. These early events are similar to those which follow acute cytolytic infections by nononcogenic viruses, and indicate that tumour-producing viruses may also stimulate conventional responses. The lymphomatous response in Marek's disease is first apparent at about 14 days after infection, and gross lymphoma formation is present by 3 to 4 weeks.
The origin of the Marek's disease lymphoma cells and the nature of their proliferation are of fundamental importance. There is good evidence that Marek's disease lymphoma is a T-cell neo-
